GRB2 and non-small cell lung carcinoma: These results suggested that circ_0002483 inhibited the progression and enhanced the Taxol sensitivity of NSCLC through the miR-182-5p/GRB2/FOXO1/FOXO3 signaling pathway (Fig. 7g).